Both of them have been reported to interact with enhancer of zeste homolog 2 (EZH2), which also functions as a H3K27 methyltransferase when part of PRC2, to epigenetically inhibit genes responsible for suppressing cancer development, and increase metastasis [82-85]. The gene discussed is EZH2; the disease is cancer.